Showing results (821-830 of 889) with videos related to
Sort By:
Pageof 89
Muscle & Nerve|July 25, 2014
Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophyAnne M Connolly, Elizabeth C Malkus, Jerry R Mendell, et al.The New England Journal of Medicine|November 2, 2017
Single-Dose Gene-Replacement Therapy for Spinal Muscular AtrophyJerry R Mendell, Samiah Al-Zaidy, Richard Shell, et al.The Review of Scientific Instruments|December 3, 2016
The Advanced LIGO photon calibratorsS Karki, D Tuyenbayev, S Kandhasamy, et al.Neuromuscular Disorders : NMD|January 23, 2023
Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathyUrsula Moore, Esther Fernández-Simón, Marianela Schiava, et al.Journal of Neuropathology and Experimental Neurology|October 6, 2006
Limb-girdle muscular dystrophy in the United StatesSteven A Moore, Christopher J Shilling, Steven Westra, et al.Frontiers in Neurology|January 4, 2021
Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With DysferlinopathyUrsula Moore, Marni Jacobs, Roberto Fernandez-Torron, et al.Cancer Cell|July 21, 2023
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancerXiaoling Li, Yunguan Wang, Su Deng, et al.Journal of Cachexia, Sarcopenia and Muscle|September 4, 2022
Water T2 could predict functional decline in patients with dysferlinopathyUrsula Moore, Ericky Caldas de Almeida Araújo, Harmen Reyngoudt, et al.Muscle & Nerve|March 2, 2016
Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-upAnne M Connolly, Julaine M Florence, Craig M Zaidman, et al.Neuromuscular Disorders : NMD|July 16, 2010
Clinical and genetic characterization of manifesting carriers of DMD mutationsPayam Soltanzadeh, Michael J Friez, Diane Dunn, et al.Pageof 89